Resveratrol might have many effects in the body, including expanding blood vessels and reducing blood clotting. It may also decrease pain and swelling, reduce levels of sugar in the blood, and help the body fight against disease.
Resveratrol is most commonly used for high cholesterol, cancer, heart disease, and many other conditions. But there is no strong evidence to support resveratrol for any use.
How does it work ?
Uses & Effectiveness
Possibly Effective for
- Hay fever. Using a nasal spray containing resveratrol three times daily for 4 weeks seems to reduce allergy symptoms in adults with seasonal allergies. Using a nasal spray containing resveratrol and beta-glucans three times daily for 2 months also seems to reduce allergy symptoms in children with seasonal allergies.
- Obesity. Some research shows that taking resveratrol can increase weight loss in obese adults.
Possibly Ineffective for
- Heart disease. People who consume higher amounts of dietary resveratrol do not seem to have a lower risk of heart disease compared to people who consume lower amounts. Also, taking resveratrol by mouth does not seem to improve levels of cholesterol or blood fats called triglycerides in people at risk for heart disease.
- A grouping of symptoms that increase the risk of diabetes, heart disease, and stroke (metabolic syndrome). Taking resveratrol doesn't seem to lower blood pressure, blood sugar, or cholesterol in people with metabolic syndrome. Early research shows that resveratrol might help to reduce body weight and body fat in people with metabolic syndrome. But more research is needed to confirm.
- Build up of fat in the liver in people who drink little or no alcohol (nonalcoholic fatty liver disease or NAFLD). Most early research shows that resveratrol does not improve liver function, liver scarring, or cholesterol levels in people with NAFLD.
Insufficient Evidence for
- Acne. Early research shows that applying a gel containing resveratrol to the face for 60 days reduces the severity of acne.
- Decline in memory and thinking skills that occurs normally with age. It is unclear if resveratrol helps with memory or thinking skills in older people. Some early research shows that resveratrol might improve thinking skills and memory in women after menopause. But other research shows that resveratrol given in higher doses or for a longer time doesn't improve memory or thinking skills in healthy older adults.
- A blood disorder that reduces levels of protein in the blood called hemoglobin (beta-thalassemia). Early research shows that taking trans-resveratrol does not improve hemoglobin levels or the need for blood transfusions in people with beta-thalassemia.
- Cancer. People who consume higher amounts of dietary resveratrol do not seem to have a lower risk of cancer compared to people who consume lower amounts.
- Diabetes. Some research shows that resveratrol improves blood sugar control in people with diabetes. But other research shows no benefit. Resveratrol might help lower blood sugar in only patients with blood sugar levels that are not well controlled. More research is needed to confirm.
- Kidney damage in people with diabetes (diabetic nephropathy). Early research shows that taking resveratrol with the drug losartan can improve some measures of kidney damage in people with diabetic nephropathy.
- A lung disease that makes it harder to breathe (chronic obstructive pulmonary disease or COPD). Early research suggests that taking a combination product containing resveratrol, vitamin C, zinc, and flavonoids slightly reduces coughing and mucus production in people with COPD. But it's not clear if the benefit is due to resveratrol or other ingredients.
- Osteoarthritis. Early research shows that adding resveratrol to standard treatments for knee osteoarthritis might improve pain, function, and stiffness more than standard treatments alone.
- Improving a medical procedure called peritoneal dialysis. Early research shows that resveratrol might make blood filtering go faster in people undergoing peritoneal dialysis.
- A hormonal disorder that causes enlarged ovaries with cysts (polycystic ovary syndrome or PCOS). Early research shows that resveratrol decreases testosterone in women with PCOS. But it doesn't improve weight, lipid levels, acne, or unwanted hair growth in women with this condition.
- Rheumatoid arthritis (RA). Taking resveratrol along with drugs for RA seems to reduce the number of painful and swollen joints. But it's not known if resveratrol also helps reduce joint damage.
- A type of inflammatory bowel disease (ulcerative colitis). Early research shows resveratrol might improve symptoms and reduce the activity of ulcerative colitis.
- Aging skin.
- Decline in memory and thinking skills in older people that is more than what is normal for their age.
- Hardening of the arteries (atherosclerosis).
- Memory and thinking skills (cognitive function).
- Other conditions.
When applied to the skin: Resveratrol is POSSIBLY SAFE when applied to the skin for up to 30 days.
Special Precautions and Warnings
Children: Resveratrol is POSSIBLY SAFE in children when sprayed in the nostrils for up to 2 months.
Bleeding disorders: Resveratrol might slow blood clotting and increase the risk of bleeding in people with bleeding disorders.
Hormone-sensitive condition such as breast cancer, uterine cancer, ovarian cancer, endometriosis, or uterine fibroids: Resveratrol might act like estrogen. If you have any condition that might be made worse by exposure to estrogen, don't use resveratrol.
Surgery: Resveratrol might increase the risk of bleeding during and after surgery. Stop using resveratrol at least 2 weeks before a scheduled surgery.
Medications that slow blood clotting (Anticoagulant / Antiplatelet drugs) interacts with RESVERATROL
Resveratrol might slow blood clotting. Taking resveratrol along with medications that also slow clotting might increase the chances of bruising and bleeding.
Some medications that slow blood clotting include aspirin, clopidogrel (Plavix), diclofenac (Voltaren, Cataflam, others), ibuprofen (Advil, Motrin, others), naproxen (Anaprox, Naprosyn, others), dalteparin (Fragmin), enoxaparin (Lovenox), heparin, warfarin (Coumadin), and others.
Medications changed by the liver (Cytochrome P450 3A4 (CYP3A4) substrates) interacts with RESVERATROL
Some medications are changed and broken down by the liver.
Resveratrol might decrease how quickly the liver breaks down some medications. Taking resveratrol along with some medications that are broken down by the liver can increase the effects and side effects of some medications. Before taking resveratrol, talk to your healthcare provider if you are taking any medications that are changed by the liver.
Some medications changed by the liver include lovastatin (Mevacor), ketoconazole (Nizoral), itraconazole (Sporanox), fexofenadine (Allegra), triazolam (Halcion), and many others.
Be cautious with this combination
- For seasonal allergies (hay fever): Two sprays of a 0.1% resveratrol nasal spray into each nostril three times/day for up to 4 weeks.
- For obesity: 500 mg or less of resveratrol daily for 3 months or longer.
CONDITIONS OF USE AND IMPORTANT INFORMATION: This information is meant to supplement, not replace advice from your doctor or healthcare provider and is not meant to cover all possible uses, precautions, interactions or adverse effects. This information may not fit your specific health circumstances. Never delay or disregard seeking professional medical advice from your doctor or other qualified health care provider because of something you have read on WebMD. You should always speak with your doctor or health care professional before you start, stop, or change any prescribed part of your health care plan or treatment and to determine what course of therapy is right for you.
This copyrighted material is provided by Natural Medicines Comprehensive Database Consumer Version. Information from this source is evidence-based and objective, and without commercial influence. For professional medical information on natural medicines, see Natural Medicines Comprehensive Database Professional Version. © Therapeutic Research Faculty 2018.